JD Health International Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Enlin Jin

Chief Executive Officer (CEO)

CN¥8.4m

Compensación total

Porcentaje del salario del CEO	15.0%
Permanencia del CEO	2.8yrs
Participación del CEO	0.01%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	3.6yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Enlin Jin en comparación con los beneficios de JD Health International?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	CN¥8m	CN¥1m	CN¥2b
Sep 30 2023	n/a	n/a	CN¥2b
Jun 30 2023	n/a	n/a	CN¥2b
Mar 31 2023	n/a	n/a	CN¥1b
Dec 31 2022	CN¥8m	CN¥1m	CN¥380m
Sep 30 2022	n/a	n/a	-CN¥7m
Jun 30 2022	n/a	n/a	-CN¥395m
Mar 31 2022	n/a	n/a	-CN¥734m
Dec 31 2021	CN¥3m	CN¥301k	-CN¥1b

Compensación vs. Mercado: La compensación total ($USD1.16M) de Enlin está en línea con el promedio de empresas de tamaño similar en el mercado Hong Kong ($USD891.84K).

Compensación vs. Ingresos: La compensación de Enlin ha sido consistente con los resultados de la empresa en el último año.

CEO

Enlin Jin (43 yo)

2.8yrs

Permanencia

CN¥8,385,000

Compensación

Mr. Enlin Jin is Chief Executive Officer & Executive Director of JD Health International Inc. from September 06, 2021. Mr. Jin has extensive experience in pharmaceuticals and TMT industry. He serves as the...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Enlin Jin	CEO & Executive Director	2.8yrs	CN¥8.39m	0.010% CN¥ 8.1m
Ying Wu	Independent Non-Executive Director	2.2yrs	CN¥818.00k	0.00030% CN¥ 235.4k
Qiangdong Liu	Chairman	3.8yrs	CN¥407.82m	0.28% CN¥ 218.5m
Qingqing Yi	Non-Executive Director	3.8yrs	sin datos	sin datos
Xingyao Chen	Independent Non-Executive Director	3.6yrs	CN¥476.00k	0.00018% CN¥ 141.2k
Ling Li	Independent Non-Executive Director	3.6yrs	CN¥476.00k	0.00018% CN¥ 141.2k
Jiyu Zhang	Independent Non-Executive Director	3.3yrs	CN¥463.00k	0.00019% CN¥ 149.1k

3.6yrs

Permanencia media

51yo

Promedio de edad

Junta con experiencia: La junta directiva de 6618 se considera experimentada (3.4 años de antigüedad promedio).

JD Health International Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

JD Health International Inc., Annual General Meeting, Jun 21, 2024

Independent Non-Executive Director recently sold HK$108k worth of stock

JD Health International Inc. Announces Chief Financial Officer Changes

High number of new and inexperienced directors

CEO & Executive Director recently sold HK$5.1m worth of stock

Independent Non-Executive Director recently sold HK$55k worth of stock

Recent updates

Now 23% undervalued after recent price drop

Now 21% undervalued

Full year 2023 earnings released: EPS: CN¥0.69 (vs CN¥0.12 in FY 2022)

JD Health International Inc., Annual General Meeting, Jun 21, 2024

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 15%

Full year 2023 earnings released: EPS: CN¥0.69 (vs CN¥0.12 in FY 2022)

JD Health International Inc. to Report Q4, 2023 Results on Mar 20, 2024

Investor sentiment deteriorates as stock falls 17%

Investor sentiment deteriorates as stock falls 16%

Investor sentiment deteriorates as stock falls 18%

First half 2023 earnings released: EPS: CN¥0.50 (vs CN¥0.072 in 1H 2022)

JD Health International Inc. to Report First Half, 2023 Results on Aug 16, 2023

Now 23% undervalued

Independent Non-Executive Director recently sold HK$108k worth of stock

JD Health International Inc. Announces Chief Financial Officer Changes

High number of new and inexperienced directors

Full year 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.35 loss in FY 2021)

CEO & Executive Director recently sold HK$5.1m worth of stock

Independent Non-Executive Director recently sold HK$55k worth of stock

First half 2022 earnings released: EPS: CN¥0.07 (vs CN¥0.15 loss in 1H 2021)

JD Health International Inc. to Report First Half, 2022 Results on Aug 23, 2022

Chairman recently sold HK$195m worth of stock

Full year 2021 earnings released: CN¥0.35 loss per share (vs CN¥7.80 loss in FY 2020)

JD Health International Inc. Announces Board Changes

JD Health International Inc. (SEHK:6618) announces an Equity Buyback for HKD 3,000 million worth of its shares.

Full year 2021 earnings released: CN¥0.35 loss per share (vs CN¥7.80 loss in FY 2020)

Independent Non-Executive Director recently sold HK$61k worth of stock

Non-Executive Director Pang Zhang has left the company

First half 2021 earnings released: CN¥0.15 loss per share (vs CN¥2.49 loss in 1H 2020)

Full year 2020 earnings released: CN¥7.80 loss per share (vs CN¥0.45 loss in FY 2019)

Non-Executive Director has left the company

Independent Non-Executive Director has left the company

Full year 2020 earnings released: CN¥7.80 loss per share

JD Health International Inc. to Report Fiscal Year 2020 Results on Mar 29, 2021